Investor Overview

Webcast ImageWebcast
FibroGen, Inc., Fourth Quarter and Full Year 2017 Financial Results Conference Call (Live)
02/27/18 at 5:00 p.m. ET
FibroGen, Inc., Fourth Quarter and Full Year 2017 Financial Results Conference Call
Tuesday, February 27, 2018 5:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
FibroGen, Inc. is a leading science-based biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics. The company applies its pioneering expertise in fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer.